Halozyme Therapeutics
HALO
110.79
+1.07
+0.98%
Halozyme Therapeutics
US · HALO
#1276 by market cap
Listed 1970
110.79
+1.07
+0.98%
Live - 5344 symbols - heartbeat 238s ago
· 2026-10-08 08:42
Pre-market
110.35
-0.40%
After-hours
110.79
0.00%
Overnight
110.00
-0.71%
- Market cap
- 12.57B
- P/E (TTM)i
- 32.49
- P/Bi
- 87.58
- EPSi
- 2.56
- Div yieldi
- 0.00%
- 52W posi
- 89%
Reader sentiment
Are you bullish or bearish on HALO?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 6 analysts
Buy
Avg price target
103.83 -6.3%
Price target rangecurrent 110.79
Low93.00
Avg103.83
High115.00
Buy 83%
Hold 17%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-03 | H.C. Wainwright | -- | BUY | 115.00 |
| 2026-09-02 | H.C. Wainwright | -- | BUY | 115.00 |
| 2026-08-18 | H.C. Wainwright | -- | BUY | 115.00 |
| 2026-08-17 | H.C. Wainwright | -- | BUY | 115.00 |
| 2026-08-07 | TD Cowen | -- | BUY | 105.00 |
| 2026-08-07 | Wells Fargo | -- | HOLD | 95.00 |
| 2026-08-07 | Citizens JMP | -- | BUY | 93.00 |
| 2026-08-07 | Morgan Stanley | -- | BUY | 105.00 |
| 2026-08-07 | Leerink Partners | -- | BUY | 110.00 |
| 2026-08-07 | H.C. Wainwright | -- | BUY | 115.00 |
| 2026-08-06 | TD Cowen | -- | BUY | 105.00 |
| 2026-08-06 | Wells Fargo | -- | HOLD | 95.00 |
| 2026-07-21 | H.C. Wainwright | -- | BUY | 95.00 |
| 2026-06-16 | H.C. Wainwright | -- | BUY | 95.00 |
| 2026-06-15 | Wells Fargo | -- | HOLD | 75.00 |
| 2026-06-15 | Morgan Stanley | -- | BUY | 93.00 |
| 2026-06-14 | Goldman Sachs | -- | SELL | 57.00 |
| 2026-05-13 | Wells Fargo | -- | HOLD | 75.00 |
| 2026-05-12 | Morgan Stanley | -- | BUY | 93.00 |
| 2026-05-12 | H.C. Wainwright | -- | BUY | 95.00 |
| 2026-05-11 | TD Cowen | -- | BUY | 96.00 |
| 2026-05-11 | Morgan Stanley | -- | BUY | 93.00 |
| 2026-05-08 | H.C. Wainwright | -- | BUY | 95.00 |
| 2026-04-29 | H.C. Wainwright | -- | BUY | 95.00 |
| 2026-04-21 | Morgan Stanley | -- | BUY | 96.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
A
Momentum strategy signal
Buy
Analyst consensus
Buy
All 3 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Improving
2
■ Upgrades■ Downgrades
- 2 upgrades vs 0 downgrades among tracked analyst rating changes.
- Most recent: Leerink Partners moved from Hold to Buy on 2026-08-07.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-08-07 | Leerink Partners | HOLD → BUY | 110.00 |
| 2025-10-14 | Leerink Partners | SELL → HOLD | 70.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | After close | ±5.86% | +20.24% (beat) |
| 2026/Q1 | 2026-05-11 | After close | ±4.56% | +6.81% (beat) |
| 2025/Q4 | 2026-02-17 | After close | ±3.38% | -9.01% (beat) |
| 2025/Q3 | 2025-11-03 | After close | ±8.54% | +2.79% (in line) |
| 2025/Q2 | 2025-08-05 | After close | ±10.38% | +2.48% (in line) |
| 2025/Q1 | 2025-05-06 | After close | ±9.53% | +18.12% (beat) |
| 2024/Q4 | 2025-02-18 | After close | ±7.72% | -0.22% (in line) |
| 2024/Q3 | 2024-10-31 | After close | ±10.11% | +13.01% (beat) |
| 2024/Q2 | 2024-08-06 | After close | ±9.63% | +4.20% (in line) |
| 2024/Q1 | 2024-05-07 | After close | ±10.63% | +1.94% (in line) |
| 2023/Q4 | 2024-02-20 | After close | ±12.36% | +6.56% (in line) |
| 2023/Q3 | 2023-11-06 | After close | ±9.66% | +10.04% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 08:42:07 · For reference only, not investment advice and not tailored to your situation.